- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Dnipro | Ukraine | International | Sales | Sales | Dec 01, 2025 |
| Customer Engagement Specialist | Kyiv | Ukraine | International | Sales | Sales | Nov 28, 2025 |
| Executive Assistant / Coordinator | Kyiv | Ukraine | International | General Management | Facilities & Administration | Nov 18, 2025 |
| Patient Access Lead | Kyiv | Ukraine | International | Other | Market Access | Mar 27, 2025 |
| Regulatory Affairs Manager | Kyiv | Ukraine | Development | Development | Research & Development | May 10, 2024 |
| New Products & Strategic Pricing Partner | Kyiv | Ukraine | International | Other | Market Access | Apr 16, 2024 |
Pagination
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى